title: Anti-TNFalpha therapy and vaccination of adults.
authors.affiliation: Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Saint-Vincent de Paul, Pôle de Médecine, Paris, France.
authors.forename: Paula
authors.initials: P
authors.lastname: Duchet-Niedziolka
authors.forename: Zoé
authors.initials: Z
authors.lastname: Coutsinos
authors.forename: Thomas
authors.initials: T
authors.lastname: Hanslik
authors.forename: Odile
authors.initials: O
authors.lastname: Launay
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology; D009894:Opportunistic Infections / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000276:immunology; D017410:Practice Guidelines as Topic; D012141:Respiratory Tract Infections / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology*; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D014409:Tumor Necrosis Factor-alpha; D014612:Vaccines